000 01382 a2200397 4500
005 20250513103819.0
264 0 _c19970312
008 199703s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(95)00711-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiegel, B W
245 0 0 _aActivities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cFeb 1996
300 _a307-18 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3T3 Cells
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aErgolines
_xpharmacology
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aLysergic Acid Diethylamide
_xmetabolism
650 0 4 _aMice
650 0 4 _aPhosphatidylinositols
_xmetabolism
650 0 4 _aRats
650 0 4 _aReceptors, Serotonin
_xdrug effects
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aSerotonin Antagonists
_xpharmacology
650 0 4 _aSerotonin Receptor Agonists
_xpharmacology
700 1 _aFreedman, J
700 1 _aVaal, M J
700 1 _aBaron, B M
773 0 _tEuropean journal of pharmacology
_gvol. 296
_gno. 3
_gp. 307-18
856 4 0 _uhttps://doi.org/10.1016/0014-2999(95)00711-3
_zAvailable from publisher's website
999 _c8896634
_d8896634